Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€6.16

€6.16

-2.760%
-0.175
-2.760%
-
 
06.02.26 / Tradegate WKN: A0Q6J0 / Name: Zur Rose Group / Stock / ? /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Zur Rose Group AG Stock

We can see a decrease in the price for Zur Rose Group AG. Compared to yesterday it has lost -€0.175 (-2.760%).
Criterium "Valuation (undervalued/overvalued)" is seen as the biggest plus for Zur Rose Group AG stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Zur Rose Group AG in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
M***** P*******
Cons
?
G***** c******* t* c**********
?
B****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

News

DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
DocMorris repurchases convertible bonds maturing in 2026 with a nominal value of around CHF 14.4 million
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
DocMorris achieves 11.1 per cent revenue growth in 2025 – strong fourth quarter
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026
DocMorris announces the results of the tender offer for its Outstanding Convertible Bonds due 2026